_version_ 1797388101586255872
author Santiago Madera
Franco Izzo
María F. Chervo
Agustina Dupont
Violeta A. Chiauzzi
Sofia Bruni
Ezequiel Petrillo
Sharon S. Merin
Mara De Martino
Diego Montero
Claudio Levit
Gabriel Lebersztein
Fabiana Anfuso
Agustina Roldán Deamicis
María F. Mercogliano
Cecilia J. Proietti
Roxana Schillaci
Patricia V. Elizalde
Rosalía I. Cordo Russo
author_facet Santiago Madera
Franco Izzo
María F. Chervo
Agustina Dupont
Violeta A. Chiauzzi
Sofia Bruni
Ezequiel Petrillo
Sharon S. Merin
Mara De Martino
Diego Montero
Claudio Levit
Gabriel Lebersztein
Fabiana Anfuso
Agustina Roldán Deamicis
María F. Mercogliano
Cecilia J. Proietti
Roxana Schillaci
Patricia V. Elizalde
Rosalía I. Cordo Russo
author_sort Santiago Madera
collection DOAJ
first_indexed 2024-03-08T22:34:52Z
format Article
id doaj.art-f97153e8a240450a80194174d2482fd7
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-08T22:34:52Z
publishDate 2023-12-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-f97153e8a240450a80194174d2482fd72023-12-17T12:31:44ZengNature Publishing GroupCell Death and Disease2041-48892023-12-0114121310.1038/s41419-023-06339-1Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancerSantiago Madera0Franco Izzo1María F. Chervo2Agustina Dupont3Violeta A. Chiauzzi4Sofia Bruni5Ezequiel Petrillo6Sharon S. Merin7Mara De Martino8Diego Montero9Claudio Levit10Gabriel Lebersztein11Fabiana Anfuso12Agustina Roldán Deamicis13María F. Mercogliano14Cecilia J. Proietti15Roxana Schillaci16Patricia V. Elizalde17Rosalía I. Cordo Russo18Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETNew York Genome CenterLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETUniversidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular and CONICET-UBA, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE)Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETDepartment of Radiation Oncology, Weill Cornell MedicineLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETServicio de Ginecología, Sanatorio Sagrado CorazónServicio de Ginecología, Sanatorio Sagrado CorazónServicio de Ginecología, Sanatorio Sagrado CorazónLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICEThttps://doi.org/10.1038/s41419-023-06339-1
spellingShingle Santiago Madera
Franco Izzo
María F. Chervo
Agustina Dupont
Violeta A. Chiauzzi
Sofia Bruni
Ezequiel Petrillo
Sharon S. Merin
Mara De Martino
Diego Montero
Claudio Levit
Gabriel Lebersztein
Fabiana Anfuso
Agustina Roldán Deamicis
María F. Mercogliano
Cecilia J. Proietti
Roxana Schillaci
Patricia V. Elizalde
Rosalía I. Cordo Russo
Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
Cell Death and Disease
title Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
title_full Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
title_fullStr Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
title_full_unstemmed Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
title_short Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
title_sort correction halting erbb 2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple negative breast cancer
url https://doi.org/10.1038/s41419-023-06339-1
work_keys_str_mv AT santiagomadera correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT francoizzo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT mariafchervo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT agustinadupont correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT violetaachiauzzi correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT sofiabruni correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT ezequielpetrillo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT sharonsmerin correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT marademartino correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT diegomontero correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT claudiolevit correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT gabriellebersztein correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT fabianaanfuso correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT agustinaroldandeamicis correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT mariafmercogliano correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT ceciliajproietti correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT roxanaschillaci correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT patriciavelizalde correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer
AT rosaliaicordorusso correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer